SARAH BARBRE: Open Payments
NPI 1477133221 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,745 in 76 payments from 29 companies in 2025. Trend: 2023 $1,103 · 2024 $1,466 · 2025 $1,745
Food & beverage: $1,650Education: $95
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $194 |
| Daiichi Sankyo Inc. | 6 | $182 |
| BeOne Medicines USA, Inc. | 9 | $162 |
| Novartis Pharmaceuticals Corporation | 8 | $161 |
| Merck Sharp & Dohme LLC | 6 | $140 |
| Janssen Scientific Affairs, LLC | 1 | $99 |
| ABBVIE INC. | 4 | $81 |
| E.R. Squibb & Sons, L.L.C. | 4 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $62 |
| Janssen Biotech, Inc. | 3 | $58 |
Products named: Enhertu, KEYTRUDA, ERLEADA, IMFINZI, TEVIMBRA, BRUKINSA, KISQALI, LYNPARZA.
Industry payments across AL — which companies pay providers there.
